Scarica l'app Stockscreener
6.09
0.49%
-0.03
Vanda Pharmaceuticals Inc Borsa (VNDA) Ultime notizie
Why did Vanda Pharmaceuticals stock slide 7% pre-market today? - MSN
Is Vanda Pharmaceuticals Inc. affected by consumer sentiment2025 Major Catalysts & Advanced Technical Analysis Signals - mfd.ru
Vanda Pharmaceuticals (NASDAQ:VNDA) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Vanda Pharmaceuticals (NASDAQ:VNDA) Raised to "Strong-Buy" at Zacks Research - MarketBeat
Vanda Pharmaceuticals Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc.VNDA - PR Newswire
Vanda Pharmaceuticals’ stock tumbles after $220M loss - The Business Journals
Vanda Pharmaceuticals Inc files for mixed shelf offering of up to $200 millionSEC filing - marketscreener.com
Why Did Vanda Pharmaceuticals Stock Slide 7% Pre-Market Today? - Stocktwits
Vanda Pharmaceuticals, The New York Islanders New Jersey Sponsor - Yahoo Sports Canada
Vanda declines on Q4 results, weak 2026 revenue guidance - MSN
Is Vanda Pharmaceuticals Inc. stock a good pick for beginners2025 Investor Takeaways & Free High Accuracy Swing Entry Alerts - mfd.ru
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2025 Earnings Call Transcript - Insider Monkey
Vanda Pharmaceuticals Inc Files For Mixed Shelf Offering Of Upto $200 MillionSEC Filing - TradingView
Vanda Pharmaceuticals Inc. SEC 10-K Report - TradingView
Will Vanda Pharmaceuticals Inc. stock benefit from green energy trendsJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - mfd.ru
Vanda Pharmaceuticals (VNDA) Eyes Growth Amidst Strong Prescription Sales and Pipeline Expansion - GuruFocus
Vanda (VNDA) Q4 2025 Earnings Call Transcript - AOL.com
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Stock Plummets 9.8% After Mixed Q4 2025 Earnings Report - ChartMill
Earnings call transcript: Vanda Pharmaceuticals Misses Q4 2025 Expectations By Investing.com - Investing.com India
Vanda Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance
Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Vanda: Q4 Financial Results Overview - Bitget
Vanda Pharmaceuticals (VNDA) Projects Lower FY26 Revenue Than Ex - GuruFocus
Vanda Pharmaceuticals (NASDAQ:VNDA) Issues Quarterly Earnings Results, Beats Expectations By $0.99 EPS - MarketBeat
Vanda: Q4 Earnings Snapshot - marketscreener.com
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire
Vanda Pharmaceuticals Q4 2025 Earnings Call Transcript - MarketBeat
What is Vanda Pharmaceuticals Inc.’s book value per share2025 Market WrapUp & AI Based Trade Execution Alerts - mfd.ru
Is Vanda Pharmaceuticals Inc. stock showing strong momentumTrend Reversal & Risk Adjusted Buy and Sell Alerts - mfd.ru
Analyst Downgrade: Will Vanda Pharmaceuticals Inc outperform tech stocksJuly 2025 Volume & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 - The Malaysian Reserve
Vanda Pharmaceuticals (VNDA) to Release Quarterly Earnings on Thursday - MarketBeat
ETF Watch: Is Vanda Pharmaceuticals Inc stock a good pick for beginnersJuly 2025 WrapUp & Community Shared Stock Ideas - baoquankhu1.vn
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Up 23.3% in January - MarketBeat
Vanda Pharmaceuticals (NASDAQ:VNDA) Stock Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
Biggest stock movers Wednesday: Vanda Pharmaceuticals, Axsome Therapeutics and Cybin - MSN
Take Profit: Can Vanda Pharmaceuticals Inc ride the EV wavePrice Action & Low Volatility Stock Suggestions - baoquankhu1.vn
Vanda Pharmaceuticals Inc. (VNDA): Investor Outlook Reveals 77% Potential Upside - DirectorsTalk Interviews
Can Bysanti Redefine Vanda's Commercial Portfolio? - RTTNews
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc.VNDA - Chartmill
Earnings Report: Can Vanda Pharmaceuticals Inc ride the EV waveForecast Cut & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc.VNDA - marketscreener.com
Vanda Pharmaceuticals (NASDAQ:VNDA) Shares Cross Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc.VNDA - FinancialContent
Vanda Stock Drop 10% Premarket After FDA Rejects Jet Lag Drug Application - MSN
Millennium Management LLC Reduces Stake in Vanda Pharmaceuticals Inc - GuruFocus
VNDA: Imminent launches and label expansions position the portfolio for major near-term growth - TradingView — Track All Markets
Lost Money on Vanda Pharmaceuticals Inc. (VNDA)? Contact Levi & Korsinsky About Fraud Investigation - marketscreener.com
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 52.3% in December - MarketBeat
Loss Report: How Vanda Pharmaceuticals Inc stock benefits from tech adoptionShort Setup & Weekly High Potential Alerts - Bộ Nội Vụ
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):